general assembly meeting

Attending the first general assembly meeting of HIVACAR consortium

HIVACAR H2020 project aims to provide a new therapeutic alternative

HIVACAR H2020 project aims to provide a new therapeutic alternative
October 27, 2017
Asphalion attended the general assembly meeting (GAM) of the HIVACAR project in Paris this July which was designed to coincide with the 9th International AIDS Society (IAS) Conference on HIV Science.
This was the first GAM of the consortium which kicked off in January 2017 with a meeting in Barcelona. In the GAM, the general status and the following project steps were discussed and agreed between the consortium members. The topics of discussion in the GAM included administrative and general management aspects, as well as scientific issues related to the clinical trial design, regulatory issues and non-clinical studies. Outreach discussion focussed on the potential psycho-social and socio-economic impact of the project. Specifically, Asphalion summarised the outcome of the previous ITF meeting, and introduced the following regulatory activities prior to the clinical trial application.
HIVACAR is an EC funded consortium and project funded under the EC Framework Programme for Research, Innovation and Technology Horizon 2020 call H2020 SC1-PM-09-2016, New therapies for chronic diseases of which Asphalion is a partner.
If you are interested and wish to have further information about HIVACAR project or Horizon 2020 program please contact us at

Search News & Events

  • Filter by category


Related news and events

SINPAIN Video | Illustrating the Future of Knee Osteoarthritis Treatment

The EU-funded research project SINPAIN aims to improve the quality of life for those affected by knee osteoarthritis (OA). By developing a new generation of advanced, safe, efficient, and cost-effective nanotherapeutics based on small interfering RNA (siRNA), the project aims to alleviate the pain experienced by knee osteoarthritis patients worldwide and reduce the significant costs associated with the disease.


‘RBDCOV Talks’ brings vaccine clinical research closer to the general audience through a podcast series with 10 scientists, clinicians, specialists and community advocates who are partners in the project.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting